Connect with us
Saturday,11-October-2025
Breaking News

Business

iPhone 13 launch: Can Apple capture a larger market share in India?

Published

on

Apple

 Apple is all set to unleash its new iPhone models on September 14. With its upcoming iPhone 13 series launch, it is primed to build on its recent growth momentum in India with a potential double-digit growth for the full year.

“I believe the new generation of iPhones will come with enhanced camera upgrades, faster A15 Bionic processor, always-on display, dynamic 120Hz refresh rates, and bigger batteries, amongst others. Increased local assembly, expanded retail initiatives including online store, aggressive marketing initiatives, and positive consumer appetite including, especially iPhone loyalists, will potentially fuel Apple’s growth.

“As we run into the all-important festive quarter, Apple does need to navigate some potential headwinds ahead, including potential supply chain constraints, and associated increase in component prices,” CMR’s Head, Industry Intelligence Group, Prabhu Ram, told IANS.

Apple registered more than 140 per cent growth in India in the second quarter this year, as iPhone 11 continued to perform well with a strong aspirational brand value, according to CMR.

iPhone 11 contributed over 60 per cent of the iPhone shipments during the April-June quarter in the country. The rest of the iPhone line-up, including Apple iPhone 12, XR and SE 2020 also performed well.

“Apple is likely to capture over 2 per cent share in 2021, its highest annual share ever. Apart from this, local manufacturing will help it to further localise its operations and save on the duties that can make help to bring the cost of its products down. Additionally, refurb market is also growing and entry to enter into Apple ecosystem can now happen from sub Rs 20K price points.

“Going forward we expect Apple and are on track to record its best annual performance in India ever since,” market intelligence firm Counterpoint’s Research Director Tarun Pathak said.

Apple has already started manufacturing certain iPhone models, including the latest iPhone 12, in India. The Cupertino-based tech giant started manufacturing iPhones in India in 2017 with iPhone SE, and now manufactures some of its most advanced iPhones in India, including XR, iPhone 11, and now iPhone 12.

“Apple was never a mass product for markets like India. It’s a gradual game for them in India and they should never go after market share by thinking of affordable iPhones. That goes against the brand image. This season, however, I see positive news for the Luxe segment (above Rs 50,000) as the target segment has rather saved money and hasn’t got affected much due to the pandemic,” techARC Founder and Chief Analyst, Faisal Kawoosa, noted.

The iPhone 13 lineup may mirror the iPhone 12 family of phones, with a 5.4-inch iPhone 13 Mini, 6.1-inch iPhone 13, 6.1-inch iPhone 13 Pro, and 6.7-inch iPhone 13 Pro Max. The devices are said to be powered by Apple’s next-generation A15 chip manufactured based on TSMC’s 5nm+ process.

The entire iPhone 13 range is also expected to sport the LiDAR sensor, which first appeared in the latest generation iPad Pro in March this year followed by the iPhone 12 Pro and iPhone 12 Pro Max.

Business

ED Seizes ₹42 Lakh, Luxury Cars In Mumbai Drug Money Laundering Probe

Published

on

Mumbai: The Enforcement Directorate (ED) seized Rs 42 lakh in cash, three luxury cars, property papers, and several digital devices during a search operation on Wednesday targeting a drug trafficking and money laundering network. The agency also froze multiple bank accounts and a locker linked to alleged drug trafficker Faisal Javed Shaikh and his wife, Alfiya Faisal Shaikh.

Officials said the searches were conducted at nine locations across Mumbai under the provisions of the Prevention of Money Laundering Act (PMLA), 2002. The operation aimed to trace the drug sale proceeds generated by a well-established narcotics network allegedly operated by the couple.

The ED initiated its money laundering probe based on a case registered by the Narcotics Control Bureau (NCB), Mumbai Zonal Unit, against multiple accused, including Faisal Shaikh, Alfiya Shaikh, and several others, including Ashik Varis Ali, Nasir Khan, Irfan Yusuf Faruqi, Azim Abu Salim Khan alias Azim Bhau, Faizan Mohd. Shafi Shaikh, and Mohd. Shahid Faridudin Chaudhary alias Baboos.

Investigators said Faisal Shaikh was procuring MD (Mephedrone) drugs from Salim Dola, a notorious drug kingpin who has been wanted by law enforcement agencies for his alleged role in large-scale narcotics trafficking. The NCB has announced a reward for information leading to Dola’s arrest.

After securing bail in the NCB case, Shaikh, described by officials as a habitual offender, was placed under preventive detention under the PIT-NDPS Act.

The ED’s probe revealed that Faisal and Alfiya Shaikh allegedly ran a structured network for the sale of MD drugs sourced from Dola. During Wednesday’s searches, the agency also covered premises connected to several individuals associated with shell companies with paper transactions exceeding Rs 100 crore, as well as firms involved in foreign outward remittances and financial dealings with the accused. Officials said these entities are being examined for their possible role in layering drug proceeds and routing the funds abroad through channels such as hawala, shell companies, and trade-based mis-invoicing.

Officials said the ED searches were critical to tracing both the “forward linkage” (movement of drug sale proceeds) and “backward linkage” (sources, beneficiaries, and conduits of funds), including whether the proceeds were channelled abroad via hawala, shell companies, or trade mis-invoicing. The seized and frozen assets including cash, bank accounts, lockers, vehicles, property documents, and digital devices are being examined under the lens of money laundering.

Continue Reading

Business

Stock markets end week on positive note; Banking, IT, and pharma stocks lead gains

Published

on

Mumbai, Oct 11: Indian equities ended the week on a positive note amid buying in banking, IT, and pharma stocks (in the last two sessions).

Investors’ sentiment remained firm toward banking stocks during the period, buoyed by the RBI monetary committee decision to keep the repo rate unchanged at 5.5 per cent, and it improved further after the government invited private sector professionals to lead the State Bank of India.

Meanwhile, pharma stocks picked up momentum at the end of the week after the US administration said that they do not plan to impose tariffs on generic drugs and signalled cutting biotech ties with flagged foreign firms, especially from China.

“Pharma stocks rallied as the US revived the Biosecure Act, aiming to cut biotech ties with flagged foreign firms, especially from China, providing a strong boost to Indian CDMOs. With the earnings season underway, investors are closely watching quarterly results for cues on market direction,” said Vinod Nair, Head of Research, Geojit Investments Limited.

On Friday, Indian equity benchmark indices ended higher for the second straight session, supported by strong buying in pharma and banking stocks.

Because of the weakness in IT stocks, the Sensex opened at 82,07,5 down about 100 points. But it quickly bounced back, rising 579 points to an intra-day high of 82,654.

At 82,501, the index ultimately closed 329 points higher, or 0.4 per cent higher. Likewise, the Nifty reached a peak of 25,331 during the day and ended the day 104 points, or 0.4 per cent, higher at 25,285.

“Investor sentiment improved after the government invited private sector professionals to lead the State Bank of India. This marks a broader policy shift towards allowing private participation in public sector enterprises, aimed at enhancing efficiency and governance,” Nair added.

The Nifty index displayed strong bullish momentum over the past week, advancing 391 points or 1.57 per cent, while Sensex rallied over 1,000 points or 1.35 per cent.

“On the weekly chart, the index has formed a cup and handle pattern, and a decisive break out of this formation, supported by increasing volumes, would signal the potential for further sustained upside,” said Hardik Matalia of Choice Equity Broking.

The Bank Nifty (up 1.84 per cent), Nifty IT (up 4.8 per cent) and Nifty Pharma (up 2.12 per cent) fueled the market momentum this week.

Continue Reading

Business

Sensex, Nifty edge higher as geopolitical tensions ease

Published

on

New Delhi, Oct 10: Indian stock markets opened on a flat note but soon moved higher on Friday, supported by positive global sentiment.

The easing of geopolitical tensions in the Middle East and signs of a possible trade deal between the US and India boosted investor confidence.

After the opening bell, the Sensex gained 148 points, or 0.18 per cent, to trade at 82,320 levels. The Nifty also rose 40 points, or 0.16 per cent, to 25,221 levels.

“Though yesterday’s push higher in the second half failed to clear the week’s high, it did serve to invalidate the bearish bias of the evening star candle stick pattern,” market experts said.

“This encourages us to look for 25460, in the days ahead. For the day, inability to push and float above 25215 or direct fall past 25113, could render the trend sideways, but may not call for a break of 24982 right away,” they added.

In the broader market, the Nifty Midcap 100 index inched up 0.18 per cent, while the Nifty Smallcap 100 advanced 0.28 per cent — indicating healthy participation from mid- and small-cap stocks.

Among the sectoral indices, Nifty Metal was the worst performer, slipping 1.4 per cent. It was followed by weakness in Auto, Pharma, and Healthcare stocks.

On the other hand, sectors such as Banking, Energy, FMCG, IT, Consumer Durables, Oil & Gas, and Realty were trading with gains.

In the Sensex pack, Power Grid, State Bank of India, NTPC, Adani Ports, and Asian Paints were among the top gainers.

Meanwhile, Tata Steel, TCS, Bajaj Finance, M&M, and HCL Tech were trading in the red.

“The overall market environment is turning positive. Globally, the GAZA peace accord signals end to the conflict and reduction of geopolitical risk from the region,” analysts said.

“Domestically, there are indications of a trade deal between US and India with India ‘rebalancing’ its oil purchases,” they added.

According to market analysts, these positive developments and the shift in FII strategy ( FIIs were buyers in the cash market in the last three trading days) bode well for the market.

Continue Reading
Advertisement
Advertisement

Trending